Dihydroberberine is a reduced isoquinoline alkaloid derived from berberine that is primarily investigated for its potential roles in the regulation of glucose and lipid metabolism. As a specialized reference… Read more
Dihydroberberine is a reduced isoquinoline alkaloid derived from berberine that is primarily investigated for its potential roles in the regulation of glucose and lipid metabolism. As a specialized reference material, this compound supports rigorous analytical testing, including impurity profiling and the development of stability-indicating methods. Laboratories utilize high-quality reference standards of Dihydroberberine, along with its associated pharmacopeial and non-pharmacopeial impurities, to ensure accurate quantification during pharmaceutical research. Additionally, stable isotope labelled compounds are available to serve as critical internal standards for mass spectrometry-based assays. These materials are essential for method validation and comprehensive quality control, enabling researchers to reliably characterize the metabolic profile and purity of related substances throughout drug development processes.